health - "review"

Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) announced that the company held a successful End-of-Phase II meeting with the U.S. Food and Drug Administration (FDA) on August 29, 2008. Following a review of the Phase II data on Microcyn® Technology for the treatment of mildly infected diabetic foot ulcers, the FDA agreed: - Oculus may move forward into the pivotal phase of its U.S. clinical program for Microcyn Technology.

First year college students believe that occasional nonmedical use of prescription pain killers and stimulants is less risky than cocaine, but more risky than marijuana or consuming five or more alcoholic beverages every weekend, according to a new study published in the September issue of Prevention Science, the peer-reviewed journal of the Society for Prevention Research.

In the online edition of Prostate Cancer and Prostatic Diseases , Dr. Jonathan Silberstein and his colleagues presented a systematic review of HIV and prostate cancer .